Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

CHMP backs Lynparza in breast cancer, Dupixent in asthma

Akcea's FDA-rejected Waylivra also recommended

- PMLiVE

Positive data unlocks more EIB funding for Nanobiotix

The cash is earmarked for its head and neck cancer drug

Brand new to PR? Keep calm and pitch on!

Entering the world of public relations (PR) I thought my understanding of what an average day would entail was comprehensive. My first 6 months as a PR professional has shown...

Say Communications

The price of healthy eating

Obesity is extremely prevalent in the UK and in the most recent reports, it has been said that two-thirds of Britons are overweight. Due to this, healthy eating and the...

Say Communications

Is Dr Google a 21st-century necessity?

On 27th September 2018, Google turned 20 years old. Throughout the last two decades, internet users have increasingly turned to Dr Google as a popular search engine to help self-diagnose...

Say Communications

Using storytelling to cut through the chatter in a crowded marketplace

11 women die every day from ovarian cancer. That is more than the number of people who die every day in road accidents. But we’ve never put out a press...

Say Communications

5 Ways to Communicate With Millennials About Healthcare

What does it mean to be a millennial? Opinions vary greatly and it is difficult to disagree on the exact definition. Metro explained the generation as babies born from the...

Say Communications

- PMLiVE

Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiry

Will be joined by chief commercial officer Stuart Arbuckle

- PMLiVE

Trump’s Brexit trade plan is bad for NHS, say campaigners

People’s Vote claims US wants to end NHS’ current regime of controlling drug costs

- PMLiVE

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

Analysts say the drug could be a best-in-class candidate in the therapy area

Biogen Idec building

Biogen strikes $800m deal to buy gene therapy firm Nightstar

Will also acquire CHM candidate and a therapy for XLRP

Gene Genie

Evolution will find new markets for gene and cell therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links